Cohance Lifesciences Limited — Updates, 07-05-2025: Name Change

Suven Pharmaceuticals has announced a board meeting to approve changing its name to Cohance Lifesciences following its merger with Cohance Lifesciences Limited. With regulatory approval secured, the company will update its records and stock exchange listings to reflect the new name. This rebranding signals a unified business identity and could enhance operational scale, positioning the company for streamlined growth and clearer market presence for shareholders.